Samenza 160 mg Tablet image 1
01 / 04

Genuine Medicines

Tracked Shipping

Plain Packaging

Order Metadata
ReferenceGH·SAMENZA1
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·SAMENZA1Anti-Cancer / Oncology Medicines

Samenza 160 mg Tablet

Enzalutamide is a prescription cancer medicine used to treat advanced prostate cancer, including cancer that has spread or no longer responds to standard hormone treatment. It works by blocking the male hormone (androgen) receptor, which prostate cancer cells need in order to grow. It is taken by mouth once daily, with or without food. It must be used only under the supervision of a cancer specialist.

Order This Product

Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.

Description

Enzalutamide belongs to a group called androgen receptor inhibitors. It blocks testosterone from attaching to the receptor, stops the receptor from moving into the cell nucleus, and prevents it from switching on genes that drive cancer growth. It is prescribed for castration-resistant prostate cancer, both when it has spread and when it has not, and for metastatic hormone-sensitive prostate cancer, usually together with a medicine or surgery that lowers testosterone. The usual dose is 160 mg once daily, taken as capsules or tablets at about the same time each day. The capsules and tablets should be swallowed whole with water and not chewed, dissolved, or opened. Common side effects include tiredness, weakness, hot flushes, joint and back pain, headache, diarrhea, and high blood pressure. It can cause seizures, so people with a history of seizures, brain injury, or stroke need extra caution, and anyone who has a seizure should stop the medicine and call a doctor. It can also cause dizziness, falls, fractures, and, rarely, a reversible brain condition (PRES) with severe headache, confusion, or vision changes. Heart problems are possible, so chest pain, breathlessness, or irregular heartbeat needs urgent attention. Strong CYP2C8 inhibitors such as gemfibrozil can raise its levels, while strong CYP3A4 inducers such as rifampicin and St. John’s wort can lower them, and it can reduce the effect of many other medicines, including warfarin. It can harm an unborn baby, so men should use effective contraception during treatment and for about three months afterward, and it is not for use by women. The dose should never be changed or stopped without the oncologist’s advice.

Specifications

Composition
Enzalutamide
Strength
160 mg
Manufacturer
Samarth
Treatment
1 x 7 Tablets
Packaging Type
Strips
Packaging Size
1 x 7 Tablets

How this product reaches you

  1. 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
  2. 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
  3. 3Your country's import rules apply — we help you understand them on chat.

Similar Products